Ferenci, P.; Asselah, T.; Foster, G. R. et al.
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trialJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. Bd. 28. 2013 S. 157-158
Moreno, Christophe; Ferenci, Peter; Asselah, Tarik et al.
Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 TrialAMERICAN JOURNAL OF GASTROENTEROLOGY. Bd. 108. 2013 S. S145-S145
Barreiros, Ana Paula; Galle, Peter R.; Otto, Gerd
Familial Amyloid PolyneuropathyDIGESTIVE DISEASES. Bd. 31. H. 1. 2013 S. 170-174
Menke, J.; Gortner, J.; Schermuly, I. et al.
Fatigue Symptoms in SLE - pathophysiological Significance of NR2-Auto-Ab.INTERNIST. Bd. 54. 2013 S. 51-52
Menke, J.; Schermuly, I.; Schwarting, A.
Fatigue-Symptoms in SLE - pathophysiological Significance of NR2-Auto-AkZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 72. 2013 S. 142-142
Triantafyllias, K.; Haeuser, F.; Rossmann, H. et al.
Fever Attacks in NOD2-Gene Mutation in Exon 4: A new Fever Syndrome?INTERNIST. Bd. 54. 2013 S. 52-53
Hohler, T.; Decker, T.; Schimanski, C. et al.
Final results of the AIO 0307 study: A controlled, randomized, double-blind phase II study of FOLFOX6 or FOLFIRI combined with sorafenib (S) vs placebo (P) in 2nd-line metastatic colorectal carcinoma (mCRC) treatmentONKOLOGIE. Bd. 36. 2013 S. 105-105
Heim, D.; Parplys, A. C.; Rose-John, S. et al.
FORCED IL-6 SIGNALING IS SUFFICIENT TO PROMOTE MALIGNANT TRANSFORMATION IN TELOMERASE-IMMORTALIZED HUMAN FETAL HEPATOCYTES FOLLOWING CHALLENGE WITH OXIDATIVE STRESSJOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S40-S41
Tanwar, S.; Parkes, J.; Trembling, P. M. et al.
FURTHER VALIDATION OF TERMINAL PEPTIDE OF PROCOLLAGEN III (PIIINP) FOR THE DETECTION AND ASSESSMENT OF NONALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASEJOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S550-S550
Tanwar, S.; Parkes, J.; Hogan, B. J. et al.
FURTHER VALIDATION OF TERMINAL PEPTIDE OF PROCOLLAGEN III (PIIINP) FOR THE DETECTION AND ASSESSMENT OF NONALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASEGUT. Bd. 62. 2013 S. A188-A188